R

Retina and Eye Consultants | Hurstville, Australia

Research site
(Unclaimed)
Location
Level 3/33 Macmahon Street, Hurstville, New South Wales, Australia
Site insights

Top conditions

Atrophy (2 trials)

Macular Degeneration (2 trials)

Geographic Atrophy (2 trials)

Macular Edema (2 trials)

Edema (2 trials)

Top treatments

APL-2
Faricimab
Dexamethasone
Pegcetacoplan
IBE-814

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 4
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD (GALE)

This is a phase 3, open-label, multicenter, extension study to evaluate the long-term safety and efficacy of pegcetacoplan (APL-2) in subjects with g...

Active, not recruiting
Geographic Atrophy Secondary to Age-related Macular Degeneration
Drug: PEGCETACOPLAN (APL-2)

This trial is a phase II, multi-center, single-masked (assessors) dose-ranging study designed to evaluate the comparative safety and preliminary effi...

Active, not recruiting
Diabetic Macular Oedema
Retinal Vein Occlusion With Macular Oedema
Drug: IBE-814 70ug
Drug: IBE-814 140ug

This study will assess a pragmatic, treat and extend regimen of faricimab against the standard of a fixed dosing regimen.

Enrolling
Diabetic Macular Edema
Drug: Faricimab

Trial sponsors

A

Apellis Pharmaceuticals (2 trials)

McMaster University logo

McMaster University (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems